WR Wealth Planners’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
$130K Buy
1,412
+58
+4% +$5.22K 0.04% 199
2024
Q3
$114K Buy
1,354
+130
+11% +$9.92K 0.03% 252
2024
Q2
$84K Buy
1,224
+84
+7% +$5.61K 0.03% 267
2024
Q1
$83.5K Buy
+1,140
New +$87.7K 0.03% 275
2023
Q4
Sell
-1,002
Closed -$75.1K 448
2023
Q3
$75.1K Sell
1,002
-187
-16% -$14.4K 0.03% 273
2023
Q2
$91.6K Sell
1,189
-34
-3% -$2.71K 0.04% 253
2023
Q1
$101K Buy
+1,223
New +$101K 0.04% 234

Other funds holding GILD

WR Wealth Planners's GILD Position: Q4 2024 in Review

WR Wealth Planners increased its Gilead Sciences (GILD) stake by 4.3% in Q4 2024, buying an estimated $5.22K and bringing the position to 1,412 shares worth $130K. The position accounts for 0.04% of the portfolio, ranked #199.

WR Wealth Planners first reported a position in GILD in Q1 2023 and has held it in 7 quarters since. 1,888 funds tracked by Wall St. Rank hold GILD as of Q4 2024.

  • WR Wealth Planners held 1,412 shares of Gilead Sciences worth $130K as of Q4 2024.
  • WR Wealth Planners bought 58 Gilead Sciences shares in Q4 2024, an estimated $5.22K.
  • Gilead Sciences made up 0.04% of WR Wealth Planners's portfolio in Q4 2024, its #199 holding.
  • WR Wealth Planners first reported a position in Gilead Sciences in Q1 2023 and has held it in 7 quarters since.
  • 1,888 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2024.

Based on WR Wealth Planners's 13F filing for Q4 2024, filed 5 Feb 2025.